Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00326092 · ClinicalTrials.gov registry record · Phase 2
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase 2 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT00326092: Completed Phase 2 study, sponsored by Alcon Research.
NCT00326092 is a Phase 2 study that has completed, run by Alcon Research. The registered enrollment target is 88 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00326092, a Phase 2 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Interventions
- DRUG Brinzolamide/Timolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2006-05 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
What the finished NCT00326092 record still lists
NCT00326092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 1 intervention - of which Brinzolamide/Timolol is the first listed.
NCT00326092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00326092 about?
NCT00326092 is a clinical study titled "A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
What is the current status of trial NCT00326092?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2006-05. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00326092?
The interventions under investigation include: Brinzolamide/Timolol (DRUG).
Who is sponsoring clinical trial NCT00326092?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00326092's enrollment target sits among peer trials
88 803rd of 2000 higher than 1,191 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia